Employees Retirement System of Texas’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,467
Closed -$184K 514
2025
Q2
$184K Buy
+1,467
New +$183K ﹤0.01% 374
2023
Q3
Sell
-108,000
Closed -$30.8M 302
2023
Q2
$30.8M Buy
108,000
+35,000
+48% +$10.4M 0.42% 82
2023
Q1
$20.3M Sell
73,000
-27,000
-27% -$7.47M 0.3% 97
2022
Q4
$27.7M Buy
100,000
+15,000
+18% +$4.24M 0.4% 79
2022
Q3
$22.7M Buy
85,000
+56,200
+195% +$11.9M 0.35% 89
2022
Q2
$5.87M Hold
28,800
0.08% 268
2022
Q1
$6.07M Buy
28,800
+5,000
+21% +$1.09M 0.07% 285
2021
Q4
$5.71M Buy
23,800
+3,000
+14% +$771K 0.06% 308
2021
Q3
$5.89M Sell
20,800
-2,100
-9% -$688K 0.07% 307
2021
Q2
$7.93M Sell
22,900
-8,900
-28% -$2.7M 0.1% 243
2021
Q1
$8.9M Sell
31,800
-2,000
-6% -$539K 0.11% 219
2020
Q4
$8.28M Hold
33,800
0.13% 184
2020
Q3
$9.59M Sell
33,800
-2,000
-6% -$558K 0.14% 177
2020
Q2
$9.58M Buy
35,800
+15,000
+72% +$4.51M 0.15% 168
2020
Q1
$6.58M Hold
20,800
0.13% 188
2019
Q4
$6.17M Sell
20,800
-6,000
-22% -$1.66M 0.1% 248
2019
Q3
$6.24M Sell
26,800
-26,200
-49% -$6.1M 0.1% 236
2019
Q2
$12.4M Sell
53,000
-1,000
-2% -$231K 0.19% 123
2019
Q1
$12.8M Sell
54,000
-18,000
-25% -$5.67M 0.19% 119
2018
Q4
$21.7M Sell
72,000
-1,400
-2% -$447K 0.34% 56
2018
Q3
$25.9M Buy
73,400
+19,700
+37% +$6.78M 0.35% 58
2018
Q2
$15.6M Sell
53,700
-8,000
-13% -$2.25M 0.21% 100
2018
Q1
$16.9M Sell
61,700
-11,200
-15% -$3.48M 0.23% 90
2017
Q4
$23.2M Sell
72,900
-2,400
-3% -$770K 0.29% 67
2017
Q3
$23.6M Buy
75,300
+2,500
+3% +$740K 0.31% 64
2017
Q2
$19.8M Sell
72,800
-16,000
-18% -$4.23M 0.27% 72
2017
Q1
$24.3M Buy
88,800
+1,300
+1% +$368K 0.33% 54
2016
Q4
$24.8M Buy
87,500
+38,600
+79% +$11.4M 0.34% 58
2016
Q3
$15.3M Buy
48,900
+18,000
+58% +$5.33M 0.21% 114
2016
Q2
$7.47M Buy
30,900
+7,000
+29% +$1.84M 0.1% 238
2016
Q1
$6.22M Buy
23,900
+11,000
+85% +$2.91M 0.09% 276
2015
Q4
$3.95M Sell
12,900
-6,300
-33% -$1.81M 0.05% 400
2015
Q3
$5.6M Sell
19,200
-18,900
-50% -$6.24M 0.08% 291
2015
Q2
$15.4M Buy
38,100
+5,000
+15% +$2.01M 0.2% 108
2015
Q1
$14M Sell
33,100
-56,000
-63% -$22.1M 0.18% 130
2014
Q4
$30.2M Buy
89,100
+11,000
+14% +$3.56M 0.38% 58
2014
Q3
$25.8M Buy
78,100
+12,270
+19% +$4.05M 0.34% 67
2014
Q2
$20.8M Sell
65,830
-28,170
-30% -$8.48M 0.27% 80
2014
Q1
$28.8M Buy
94,000
+13,000
+16% +$4.13M 0.38% 57
2013
Q4
$22.7M Buy
81,000
+4,470
+6% +$1.16M 0.29% 73
2013
Q3
$18.4M Sell
76,530
-10,470
-12% -$2.34M 0.23% 86
2013
Q2
$18.7M Buy
+87,000
New +$18.6M 0.22% 82

Other funds holding BIIB

Employees Retirement System of Texas's BIIB Position: Q3 2025 in Review

Employees Retirement System of Texas sold out of Biogen (BIIB) in Q3 2025, closing a stake of 1,467 shares — an estimated $184K sold.

Employees Retirement System of Texas first reported a position in BIIB in Q2 2013 and held it in 42 quarters. The position peaked at $30.8M in Q2 2023. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Employees Retirement System of Texas reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 1,467 Biogen shares in Q3 2025, an estimated $184K.
  • Employees Retirement System of Texas first reported a position in Biogen in Q2 2013 and held it in 42 quarters.
  • Employees Retirement System of Texas's Biogen position peaked at $30.8M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Employees Retirement System of Texas's 13F filing for Q3 2025, filed 13 Nov 2025.